Fentanyl is an opioid analgesic drug. Subcutaneous fentanyl can be considered for patients in whom subcutaneous morphine is contraindicated. It has been investigated as an intervention to relieve breakthrough dyspnea in patients who have cancer. Healthcare professionals should be aware of the different formulations for these medications, the length of their half-life, and the onset of action.